Amicus Therapeutics

FOLD | NASDAQ | 0 Obserwujący

$6.16

-2.14%

-$0.14

Obserwuj

Overview Metrics Financials

Fair Price

$42.07

Undervalued by 63.3%

Aby wyświetlić sprawiedliwą cenę akcji, musisz być członkiem Bulios Black.

Profile

Amicus Therapeutics, Inc. is an American biotechnology company specializing in the development of innovative therapies for the treatment of rare genetic diseases, particularly lysosomal storage disorders. The company focuses on developing enzyme replacement therapies and other biologic treatments that can improve the health of patients suffering from diseases such as Fabry disease, Gaucher disease, and Pompe disease. Amicus Therapeutics is known for its advanced research in enzyme therapy and highly targeted treatment methods, offering new possibilities for patients for whom current treatments have been insufficiently effective.

Feed

There are no posts to show right now.

Amicus Therapeutics

Fair Price

Profile

Feed

Zaloguj się do Bulios

Utwórz profil Bulios

Dlaczego Bulios?